| 000 | 01052 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517085823.0 | ||
| 264 | 0 | _c20170612 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1572-0241 | ||
| 024 | 7 |
_a10.1038/ajg.2016.105 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWungjiranirun, Manida | |
| 245 | 0 | 0 |
_aCurrent Status of Celiac Disease Drug Development. _h[electronic resource] |
| 260 |
_bThe American journal of gastroenterology _c06 2016 |
||
| 300 |
_a779-86 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 |
_aCeliac Disease _xdrug therapy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDiet, Gluten-Free |
| 650 | 0 | 4 | _aDrug Discovery |
| 650 | 0 | 4 |
_aGastrointestinal Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aKelly, Ciaran P | |
| 700 | 1 | _aLeffler, Daniel A | |
| 773 | 0 |
_tThe American journal of gastroenterology _gvol. 111 _gno. 6 _gp. 779-86 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/ajg.2016.105 _zAvailable from publisher's website |
| 999 |
_c25870177 _d25870177 |
||